We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00209664
Recruitment Status : Suspended
First Posted : September 21, 2005
Last Update Posted : February 2, 2006
Sponsor:
Information provided by:

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Primary Completion Date : No date given
  Estimated Study Completion Date : December 2008